Cocrystal engineering of oxyresveratrol
- document 1 document 2 document 3
- niveau 1 niveau 2 niveau 3
- audio 1 audio 2 audio 3
Descriptif
Oxyresveratrol (ORV) is a compound found in the heartwood of Artocarpus lakoocha Roxburgh (Moraceae). It has diverse biological and therapeutic activities covering antioxidant, anti-inflammatory, neuroprotective, antimicrobial. However, it has poor water solubility, oral availability and stability which challenge to delivery design and product development. Cocrystal engineering has been reported to be able to modify the physicochemical properties of a chemical compound and produce a superior chemical candidate for formulation design. 77 cocrystal formers with various functional groups were used for cocrystal screening via grinding, liquid-assisted grinding, solvent evaporation and slurry methods. Eight cocrystals (ORV with citric acid, glutaric acid, betaine, L-proline, isonicotinamide, nicotinamide, urea and ethyl maltol) were successfully produced and characteristic crystal properties were confirmed by powder X-ray diffraction, low frequency Raman spectroscopy and thermal analysis. The ORV-citric acid cocrystal showed enhanced solubility and permeability across the human intestinal tract. While the crystal structures of ORV-betaine and ORV-proline cocrystals were identified and solved by single-crystal X-ray diffraction. Therefore, cocrystallization could be applied to design novel parent molecules including drugs, herbal substances and vitamin for innovative delivery systems.
Thèmes
Notice
Dans la même collection
-
Agricultural by-products valorization
Winemaking generates different biomolecule-rich byproducts, including pomaces (skin and seeds), lees, as well as other solid wastes like grape canes.
-
The Mint family (Lamiaceae) in Thailand- A potential material source for phytocosmeceutical applica…
Lamiaceae is the large family, consisting of more than 7,000 species worldwide
-
Quality Evaluation of Rehmannia glutinosa by Morphological, Genetic and Chemical Study
Previously, the medicinal plant, Rehmannia glutinosa, is grouped into two types in Japan. However, previous reports of genetic analysis of R. glutinosa in commercial products suggest the existence of
-
Molecular network
Specialised metabolites constitute a high valuable resource of bio-active compounds that are highly sought after for pharmaceutic and cosmetic applications. However, plant extracts are very complex
-
Green extraction of Thai medicinal plants
Extraction is a major step to separate bioactive compounds from raw material and medicinal plants, which extracted by the pharmaceutical industry, either with conventional methods or modern
-
Natural Deep Eutectic Solvents: fad or real opportunity?
NaDES appeared at the end of the 2010s following the work of Dai et al. Since then, the enthusiasm for these new green solvents linked to ionic liquids has continued to grow.
Sur le même thème
-
Dr Lori L. Isom - Dancing to a different tune: TANGO offers a precision medicine approach to treati…
Dravet syndrome is an intractable developmental and epileptic encephalopathy caused largely by de novo variants in SCN1A resulting in haploinsufficiency of the voltage-gated sodium channel α subunit
-
Prof. Michelle L. Hastings - Antisense Oligonucleotides for the Treatment of Disease
Antisense oligonucleotides (ASOs) have proven to be an effective therapeutic platform for the treatment of disease.
-
Dr Ana Cristina Calvo - Peripheral RNA Biomarkers in Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease of unknown origin that causes progressive muscle paralysis and motor neuron death.
-
Prof. Antonella Riccio - RNA metabolism in developing neurons
Neurons are cells with a complex morphology, which maintain their cellular structure through the compartmentalized expression of proteins essential for growth and plasticity.
-
Dr Débora Lanznaster - Combined Metabolomics and targeted-transcriptomics analysis in the muscle of…
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by the progressive loss of motor neurons, leading to paralysis and death of patients after 3-5 years of symptoms’ onset
-
Director Jason Potter - What matters for making highly expressed mRNA.
The need for high quality mRNA for therapeutic applications has grown substantially over the last few years due to the efficacy of the COVID mRNA vaccines.
-
Dr Horacio Cabral - RNA/Polymer-Based Supramolecular Approaches for mRNA Delivery
Messenger RNA (mRNA) therapeutics are attracting much attention, particularly after the approval of two mRNA vaccine formulations for COVID-19.
-
Prof. Krzystof Sobczak - Compounds which alleviate the pleiotropic toxicity of RNA harboring expand…
Fragile X-associated tremor/ataxia syndrome (FXTAS) is an incurable neurodegenerative disorder caused by expansion of CGG repeats in the FMR1 5'UTR.
-
Prof. Steven Dowdy - Delivery of RNA Therapeutics: The Great Endosomal Escape!
All macromolecular therapeutics, including ASOs, siRNAs, peptides, proteins, CRISPR, mRNA and non-viral DNA vectors, are taken up into cells by endocytosis.
-
Dr Liliane Massade - Squalenoyl siRNA PMP22 nanoparticles, a potent therapy for Charcot-Marie-Tooth…
Charcot-Marie-Tooth disease type 1A (CMT1A), caused by a duplication in chromosome 17, results in peripheral myelin protein 22 (Pmp22) over-expression and axon demyelination.
-
Prof. Jernej Ule - How do protein-RNA condensates form and contribute to disease?
Mutations in many genes encoding RNA-binding proteins (RBPs) cause neurologic diseases, and especially the amyotrophic lateral sclerosis (ALS).
-
Prof. Stefano Gustincich - Antisense long non-coding SINEUP RNAs: from molecular mechanism to thera…
Natural SINEUPs are antisense long non-coding RNAs that enhance translation of sense mRNAs. Their activity depends on the combination of two domains: the overlapping region, or binding domain (BD),
